BSC-1020

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBSC-1020
Drug Alias NameNeupogen biosimilar (Biosimilar Solutions)BSC-1020
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCaribbean Islands
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesBiosimilar Solutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiosimilar Solutions Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A